Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Shanghai Stock Exchange 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Interest Coverage Ratio for the year ending December 31, 2023: 48.14

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Interest Coverage Ratio is 48.14 for the year ending December 31, 2023, a -4.49% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Interest Coverage Ratio for the year ending December 31, 2022 was 50.40, a 62.77% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Interest Coverage Ratio for the year ending December 31, 2021 was 30.97, a 174.11% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Interest Coverage Ratio for the year ending December 31, 2020 was 11.30, a -61.89% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Interest Coverage Ratio for the year ending December 31, 2019 was 29.64, a -39.86% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shanghai Stock Exchange: 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

CEO	Mr. Yi Jiang Mei
IPO Date	Oct. 10, 2014
Location	China
Headquarters	99 Waisha Road
Employees	4,877
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Key trends

Past 5 years